zt006
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 28, 2024 (NCT07307638)
Timeline
Mechanism of action
- Disks large homolog 4INHIBITOR
DLG4 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07230132 | Phase 2 | Dec 31, 2025 | Beijing QL Biopharmaceutical Co.,Ltd, Peking University |
| NCT07307638 | Phase 1 | Nov 28, 2024 | Anhui Medical University, Beijing QL Biopharmaceutical Co.,Ltd |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Beijing QL Biopharmaceutical Co.,Ltd | For profit | 2 | 2 | 2 | 2024 |
| Anhui Medical University | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Peking University | Academic/Hospital | 1 | 0 | 1 | 2025 |
3 organizations
Page 1 / 1